Tuberculosis trials in Kenya

4 of 7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

  Where

  Kericho

  Age

  Up to 13 years

  People

  144 worldwide

  Run by

  National Institute of Allergy and Infectious Diseases (NIAID)

  See details and how to joinNCT07124559
• No phaseTaking people
  Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission

  Where

  Kisumu

  People

  1,500

  Run by

  University of Washington

  See details and how to joinNCT07628140
• Phase 2Not yet taking people in Kenya
  A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

  Where

  Eldoret, Kericho

  Age

  13 years and over

  People

  900 worldwide

  Run by

  National Institute of Allergy and Infectious Diseases (NIAID)

  See details and how to joinNCT07595042
• Phase 2Taking people
  Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

  Where

  Eldoret, Kericho

  Age

  15 years and over

  People

  330 worldwide

  Run by

  National Institute of Allergy and Infectious Diseases (NIAID)

  See details and how to joinNCT05383742